James Davis, MD

Associate Professor of Medicine
Member of the Duke Cancer Institute
Email address james.m.davis@duke.edu

Dr. James Davis is a practicing physician of Internal Medicine, and serves as the Medical Director for Duke Center for Smoking Cessation, Director of the Duke Smoking Cessation Program and Co-Director of the Duke-UNC Tobacco Treatment Specialist Credentialing Program.  His research focuses on development of new pharmaceutical treatments for smoking cessation.  He is principal investigator on several trials including a study on “adaptive” smoking cessation and several trials on new medications for smoking cessation. The new medications leverage more novel neurobiological mechanisms - NMDA receptor antagonism, nicotinic receptor antagonism, which impact addiction-based learning and cue response. Additionally, Dr. Davis serves as co-investigator on trials on lung cancer screening, e-cigarettes, minor nicotine alkaloids, imaging trials, lung function trials and others. Dr. Davis leads the Duke Smoke-Free Policy Initiative, is co-author on a national  tobacco dependence treatment guideline, and provides training in tobacco dependence treatment for the Duke School of Medicine, Duke Internal Medicine, Family Practice and Psychiatry residency programs. 

Education and Training

  • Internal Medicine Residency, Mayo Clinic, 1997 - 2000
  • M.D., Southern Illinois University, School of Medicine, 1997

Publications

Golden, Sara E., Sarah S. Ono, Anne Melzer, James Davis, Steven B. Zeliadt, Jaimee L. Heffner, Hasmeena Kathuria, Ginny Garcia-Alexander, and Christopher G. Slatore. “"I Already Know That Smoking Ain't Good for Me": Patient and Clinician Perspectives on Lung Cancer Screening Decision-Making Discussions as a Teachable Moment.” Chest 158, no. 3 (September 2020): 1250–59. https://doi.org/10.1016/j.chest.2020.03.061.

PMID
32304776
Full Text

Rose, Jed E., and James M. Davis. “Combination Lorcaserin and Nicotine Patch for Smoking Cessation Without Weight Gain.” Nicotine Tob Res 22, no. 9 (August 24, 2020): 1627–31. https://doi.org/10.1093/ntr/ntz149.

PMID
31589323
Full Text

Davis, James M., Leah C. Thomas, Jillian E. H. Dirkes, and H Scott Swartzwelder. “Strategies for Referring Cancer Patients in a Smoking Cessation Program.” Int J Environ Res Public Health 17, no. 17 (August 21, 2020). https://doi.org/10.3390/ijerph17176089.

PMID
32825665
Full Text

Davis, James M., Leah C. Thomas, Jillian Eh Dirkes, Santanu K. Datta, and Paul A. Dennis. “Comparison of referral methods into a smoking cessation program.” J Comp Eff Res 9, no. 11 (August 2020): 807–15. https://doi.org/10.2217/cer-2020-0004.

PMID
32795088
Full Text

Datta, Santanu K., Paul A. Dennis, and James M. Davis. “Health benefits and economic advantages associated with increased utilization of a smoking cessation program.” J Comp Eff Res 9, no. 11 (August 2020): 817–28. https://doi.org/10.2217/cer-2020-0005.

PMID
32815740
Full Text

Pacek, Lauren R., Alicia D. Holloway, Karen L. Cropsey, Christina S. Meade, Maggie M. Sweitzer, James M. Davis, and F Joseph McClernon. “Cigarette Smoking and Cessation-Related Interactions With Health Care Providers in the Context of Living With HIV: Focus Group Study Findings.” J Assoc Nurses Aids Care, July 2, 2020. https://doi.org/10.1097/JNC.0000000000000185.

PMID
32639266
Full Text

Blair, Graham, Corinne Wells, Ashley Ko, John Modarres, Caroline Pace, James M. Davis, Amir H. Rezvani, Jed E. Rose, and Edward D. Levin. “Dextromethorphan and bupropion reduces high level remifentanil self-administration in rats.” Pharmacol Biochem Behav 193 (June 2020): 172919. https://doi.org/10.1016/j.pbb.2020.172919.

PMID
32246985
Full Text

Datta, Santanu, James Davis, and Paul Dennis. “USE OF THE ELECTRONIC HEALTH RECORD TO INCREASE PATIENT ENGAGEMENT IN A SMOKING CESSATION PROGRAM (SCP).” In Medical Decision Making, 40:E246–E246. SAGE PUBLICATIONS INC, 2020.

Scholars@Duke

Kragel, Emily A., Maggie M. Sweitzer, and James M. Davis. “The Effect of Brief Mindfulness Training on Brain Reactivity to Food Cues During Nicotine Withdrawal: A Pilot Functional Imaging Study.” Mindfulness (N Y) 10, no. 11 (November 2019): 2272–76. https://doi.org/10.1007/s12671-019-01201-y.

PMID
31687047
Full Text

Pages